Tompkins, D. Andrew, M.D.

Assistant Professor Behavioral Pharmacology Research Unit (BPRU) Main Office Address Johns Hopkins Bayview Medical Center 5510 Nathan Shock Drive Baltimore, MD 21224 Phone: 410-550-5953 Fax: 410-550-0030 E-mail: dtompki1@jhmi.edu

Education

Professional Interests

Applying quantitative sensory testing to better understand the treatment of pain in persons addicted to opioids. Conducting clinical trials for the development of novel medications in the treatment of substance use disorders. Abuse liability testing.

Dr. Andrew Tompkins' Curriculum Vitae

Selected Publications

Tompkins DA, Bigelow GE, Harrison JA, Johnson RE, Fudala PJ, Strain EC. “Concurrent validation of the Clinical Opiate Withdrawal Scale (COWS) and single-item indices against the Clinical Institute Narcotic Assessment (CINA) opioid withdrawal instrument.” Drug Alc Dep. 2009 Nov; 105(1-2)154-9. 

Tompkins DA, Lanier RK, Harrison JA, Strain EC, Bigelow GE. Human abuse liability assessment of oxycodone combined with ultra-low-dose naltrexone.” Psychopharm 2010 Jul; 210(4)471-80.

Tompkins DA, Campbell CM. “Opioid induced hyperalgesia: clinically relevant or extraneous research phenomenon?” Curr Pain Headache Rep 2011; 15(2):129-36.

Byne W, Bradley SJ, Coleman E, Eyler AE, Green R, Menvielle EJ, Meyer-Bahlburg HFL, Pleak RR, Tompkins DA. Report of the American Psychiatric Association Task Force on Treatment of Gender Identity Disorder. Arch Sex Behav. 2012 Aug; 41(4):759-96.

Tompkins DA, Smith MT, Bigelow GE, Moaddel R, Vatem Venkata SL, Strain EC. “The effect of repetitive intramuscular alfentanil injections on experimental pain and abuse liability in healthy males.” Clin J Pain. 2013 (in press).